SHL Telemedicine (XSWX:SHLTN) Risk Assessment

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:SHLTN SHL Telemedicine Ltd XSWX:SHLTN
53 GF Score
Price CHF1.04
GF Value CHF2.62
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is SHL Telemedicine Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of SHL Telemedicine is: High Risk: High uncertainty.

SHL Telemedicine  (XSWX:SHLTN) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

SHL Telemedicine Risk Assessment Related Terms

XSWX:SHLTN vs VEEV, BTSG, HQY: Risk Assessment Comparison

For the Health Information Services subindustry, SHL Telemedicine's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SHL Telemedicine Risk Assessment vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, SHL Telemedicine's Risk Assessment distribution charts can be found below:

* The bar in red indicates where SHL Telemedicine's Risk Assessment falls into.


XSWX:SHLTN
53GF Score
SHL Telemedicine Ltd XSWX:SHLTN
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is SHL Telemedicine (XSWX:SHLTN) Overvalued in 2026?

Based on GuruFocus' analysis, SHL Telemedicine stock appears to be undervalued. The current stock price of CHF1.04 is trading 60.3% below its estimated GF Value™ of CHF2.62. GuruFocus considers SHL Telemedicine to be Possible Value Trap.

Key valuation signals for XSWX:SHLTN:

  • Risk Assessment:
  • GF Value™: CHF2.62 vs. price of CHF1.04 (60.3% below fair value)
  • GF Score™: 53/100 with 6 warning signs

No single metric tells the full story. See the XSWX:SHLTN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SHL Telemedicine Business Description

Other Exchanges 0QMX:UK
Address 90 Yigal Alon Street, Tel Aviv, ISR, 67891
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. The company consists of the transmission of medical data by an individual, from a remote location to a medical call center, through telecommunication networks. The company provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments are Israel, Europe, and the rest of the world, out of which majority of revenue comes from Israel.
53GF Score

Get the complete analysis for XSWX:SHLTN

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF1.04
Price
CHF2.62
GF Value